Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/16/2008WO2008122378A1 Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
10/16/2008WO2008122357A1 5-oxo-isoxazoles as inhibitors of lipases and phospholipases
10/16/2008WO2008122356A1 Cardiovascular agents
10/16/2008WO2008122352A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008WO2008122314A1 Rna interference tags
10/16/2008WO2008122214A1 The use of low molecular weight fucoidan in preparing of medicine for treating kidney diseases
10/16/2008WO2008122198A1 Non-steroidal androgen acceptor regulators and their medical use
10/16/2008WO2008122190A1 The composition comprising l-carnitine or derivatives thereof and its use
10/16/2008WO2008122119A1 Perfluoroketone compounds and uses thereof
10/16/2008WO2008122115A1 Inhibitors of histone deacetylase
10/16/2008WO2008122104A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122102A1 Melatonin-based composition for improved sleep
10/16/2008WO2008122100A1 Composition for supporting restful sleep comprising valerian root extract and methylcobalamim
10/16/2008WO2008122098A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells
10/16/2008WO2008122087A1 Methods for treating pervasive developmental disorders
10/16/2008WO2008106659A3 Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith
10/16/2008WO2008106479A3 Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production
10/16/2008WO2008106047A3 Carbamate compounds
10/16/2008WO2008101141A3 Cancer treatment method
10/16/2008WO2008100933A3 Reducing side effects of tramadol
10/16/2008WO2008099416A3 Novel benzothiazole and benzoxazole linked pyrrolo[2,1-c] [1, 4] benzodiazepine hybrids as novel antitumour agents and process for the preparation thereof
10/16/2008WO2008096149A3 Napadisylate salt of a muscarinic m3 antagonist
10/16/2008WO2008094321A3 Akt sensitization of cancer cells
10/16/2008WO2008094208A3 Protein kinase targeted therapeutics
10/16/2008WO2008093358A3 Aqueous topical solution containing olopatadine
10/16/2008WO2008093221A3 Pharmaceutical compositions containing pde4 inhibitor for the treatment of inflammatory and allergic disorders
10/16/2008WO2008091946A3 N-amino tetrahydrothiazine derivatives, method of manufacture and use
10/16/2008WO2008091752A3 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents
10/16/2008WO2008088836A3 Compositions and methods for treatment of colorectal cancer
10/16/2008WO2008088803A3 Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones
10/16/2008WO2008088314A3 A composition for the treatment and prevention of peptic ulcer
10/16/2008WO2008086122A3 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/16/2008WO2008085872B1 Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
10/16/2008WO2008084171A3 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component
10/16/2008WO2008083248A3 Cyclopamine analogs
10/16/2008WO2008082601A3 Compounds and pharmaceutical compositions for the treatment of viral infections
10/16/2008WO2008079988A3 Quinazolines for pdk1 inhibition
10/16/2008WO2008079945A3 Rock inhibitors and uses thereof
10/16/2008WO2008079460A3 Tyrosine kinase inhibitors for prevention or treatment of infection
10/16/2008WO2008077647A3 Alpha- amino alcohols as non-steroidal progesterone receptor modulators
10/16/2008WO2008077027A3 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders
10/16/2008WO2008076883A3 Triazine derivatives and their therapeutical applications
10/16/2008WO2008073863A3 Preparation and utility of substituted allylamines
10/16/2008WO2008073858A3 Cancer chemoprevention strategy based on loss of imprinting of igf2
10/16/2008WO2008070462A3 N-oxides of 4,5-epoxy-morphinanium analogs
10/16/2008WO2008070116A3 Topical compositions for treatment of skin conditions
10/16/2008WO2008069976A3 Compounds and methods for enzyme-mediated tumor imaging and therapy
10/16/2008WO2008069970A3 Nicotine formulations, kits and systems and methods for their use
10/16/2008WO2008068770A3 Pharmaceutical composition containing bicalutamide and a method for its use
10/16/2008WO2008067491A3 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
10/16/2008WO2008067039A9 Colchicine neoglycosides and methods for their synthesis and use
10/16/2008WO2008064615A3 Crystalline and amorphous forms of rimonabant and processes for obtaining them
10/16/2008WO2008063865A3 Biphosphonate inhalant formulations and methods for using the same
10/16/2008WO2008063562A3 Materials and methods of introducing genetic material into living cells
10/16/2008WO2008063341A3 Dual action, inhaled formulations providing both an immediate and sustained release profile
10/16/2008WO2008062476A3 Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
10/16/2008WO2008060578A3 3-aryl-6-aryl-[1,2,4] triazolo[3,4-b][1,3,4] thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof
10/16/2008WO2008058995A3 Use of cytohesin inhibitors for chemically inducing longevity
10/16/2008WO2008058547A3 Alpha-lactalbumin composition
10/16/2008WO2008057337A3 Use of dipeptidyl peptidase iv inhibitors for preventing, delaying or reducing the occurance of edema
10/16/2008WO2008055995A3 Methods and compositions for detecting receptor ligand mimetics
10/16/2008WO2008052722A3 Use of ribavirin-conjugates as an anti-viral drug
10/16/2008WO2008048668A3 Novel inhibitors of chymase
10/16/2008WO2008048503A3 Imidazole substitured pyrazole kinase inhibitors
10/16/2008WO2008042139A3 Azithromycin for the treatment of nodular acne
10/16/2008WO2008041133A3 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases
10/16/2008WO2008033858A3 Kinase inhibitors, and methods of using and identifying kinase inhibitors
10/16/2008WO2008030391A3 Difluorinated piperidines for treatment of alzheimer's disease and related conditions
10/16/2008WO2008027899A3 Methods and compositions related to apobec-1 expression
10/16/2008WO2008027442A3 Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
10/16/2008WO2008027419A3 Tizanidine sulfate salt forms and methods of making and using the same
10/16/2008WO2008027182A3 Indoloquinoline compounds as calcium channel blockers
10/16/2008WO2008026156A3 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
10/16/2008WO2008024858A3 Methods and compounds regulating the erythroid response to iron deficiency
10/16/2008WO2008024749A3 Methods and compositions for treating ischemic stroke
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008WO2008021745A3 Hepatitis c virus entry inhibitors
10/16/2008WO2008021725A3 Chemical compounds
10/16/2008WO2008021404A3 Method for treating generalized and focal peripheral neuropathies
10/16/2008WO2008020421A3 Compositions comprising calcium citrate malate and methods for making the same
10/16/2008WO2008019785A3 Transdermal application of triazines for controlling coccidia infections
10/16/2008WO2008019351A3 Compositions and their uses directed to diacylglycerol acyltransferase 1
10/16/2008WO2008014296A3 Composition and method for treatment of tumors
10/16/2008WO2008014240A3 Dimeric iap inhibitors
10/16/2008WO2008011513B1 Compounds and methods of modulating angiogenesis
10/16/2008WO2008011083A3 Compounds for enhancing arginase activity and methods of use thereof
10/16/2008WO2008010963A3 Immune response modifier formulations
10/16/2008WO2008008276A3 Tetracycline repressor regulated oncolytic viruses
10/16/2008WO2008006071B1 Blends of fullerene derivatives, and uses thereof in electronic devices
10/16/2008WO2008005560A3 Prevention of thrombotic disorders with active vitamin d compounds
10/16/2008WO2008002678A3 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
10/16/2008WO2008002514A3 Combination cough treatment compounds and method of treating common coughs
10/16/2008WO2007149456A3 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/16/2008WO2007135362A3 Stable aqueous suspension having palatable taste
10/16/2008WO2007134595A3 Novel formulation, oriented to tumour physiology, of a cytostatic, in particular of cis-platinum
10/16/2008WO2007134271A3 Method and apparatus for reducing injury from acute myocardial infarction
10/16/2008WO2007130783A3 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
10/16/2008WO2007121481A8 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
10/16/2008WO2007120897A3 Compositions and intraluminal devices for inhibiting vascular stenosis
10/16/2008WO2007118084A3 Compositions and methods for treating polycystic kidney disease
1 ... 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 ... 7860